# FDA Submission Documentation

## 510(k) Pre-Submission Package

**Date**: TBD
**Sponsor**: Clinical AI Team
**Device**: Wound Segmentation System
**Classification**: Class II (21 CFR 892.2070)

## Intended Use

Wound Segmentation System is indicated for use as a software medical device that provides pixel-wise segmentation of wound boundaries in digital images of skin wounds for clinical assessment purposes.

## Indications for Use

- Adult patients (18+) with chronic wounds
- Wound types: pressure ulcers, diabetic ulcers, venous ulcers
- Clinical settings: hospitals, wound care centers, home health
- Not for wounds in delicate areas (face, hands) without physician oversight

## Performance

| Metric | Target | Validation |
|--------|--------|------------|
| Dice Score | >= 0.85 | Internal validation set (n=200) |
| Sensitivity | >= 0.90 | Cross-validation |
| Specificity | >= 0.95 | Cross-validation |
| Inter-rater reliability | >= 0.85 | Physician agreement study |

## Software Description

- Architecture: U-Net with ResNet34 encoder
- Input: RGB image (384x384 default)
- Output: Binary wound mask
- Deployment: Docker container, REST API

## Design Controls

- Requirements: `config/clinical_config.yaml`
- Architecture: `docs/technical/architecture.md`
- Risk Analysis: `docs/regulatory/risk_analysis.md`
- Clinical Protocol: `docs/clinical/clinical_protocol.md`

## Verification & Validation

- Unit tests: `tests/unit/`
- Integration tests: `tests/integration/`
- Clinical validation: `tests/clinical/`
- Performance metrics: `src/metrics/`

---
*Note: This document is a placeholder for actual FDA submission preparation.*
